本文選題：化療栓塞 + 清宮術(shù)��； 參考：《中國(guó)介入影像與治療學(xué)》2017年01期

【摘要】：目的探討子宮動(dòng)脈化療栓塞術(shù)(UACE)治療剖宮產(chǎn)子宮瘢痕妊娠(CSP)的療效及安全性。方法對(duì)26例CSP患者UACE后行清宮術(shù),觀察并記錄UACE和清宮術(shù)的并發(fā)癥、血清β-HCG和月經(jīng)恢復(fù)正常的時(shí)間,對(duì)UACE前和術(shù)后1天、4天、1周血清β-HCG進(jìn)行對(duì)比;根據(jù)UACE前血清β-HCG水平將患者分為A組(血清β-HCG≥10 000mIU/ml)和B組(血清β-HCG10 000mIU/ml),對(duì)比組間孕周、前次剖宮產(chǎn)距今時(shí)間、清宮術(shù)中出血量的差異。結(jié)果 UACE技術(shù)成功率為100%;術(shù)后陰道出血均得到有效控制,清宮術(shù)中出血量5~400 ml,無(wú)嚴(yán)重并發(fā)癥發(fā)生;UACE前和術(shù)后1天、4天、1周血清β-HCG差異有統(tǒng)計(jì)學(xué)意義,UACE術(shù)后血清β-HCG較術(shù)前顯著下降;兩組年齡、孕周、前次剖宮產(chǎn)距今時(shí)間、清宮術(shù)中出血量差異均無(wú)統(tǒng)計(jì)學(xué)意義(P均0.05),兩組既往孕次、血清β-HCG降至正常的時(shí)間差異均有統(tǒng)計(jì)學(xué)意義(P均0.05)。結(jié)論 UACE在CSP的治療中有較好的療效及安全性,無(wú)論血清β-HCG水平高低,均可達(dá)到保留子宮和生育能力目的。
[Abstract]:Objective to evaluate the efficacy and safety of uterine arterial chemoembolization (UACEE) in the treatment of cesarean scar pregnancy. Methods 26 patients with CSP were treated with uterine clearance after UACE. The complications, serum 尾 -HCG and menorrhagia were observed and recorded. Serum 尾 -HCG was compared before UACE and 1 week after UACE. According to the serum 尾 -HCG level before UACE, the patients were divided into two groups: group A (serum 尾 -HCG 鈮，

本文編號(hào)：1797550